首页 › 基金 › General Catalyst Group Management, LLC › MAZE

General Catalyst Group Management, LLC 对 MAZE 的持仓历史

MAZE THERAPEUTICS INC · 医疗保健

General Catalyst Group Management, LLC 在 Q2 2026 的 13F 申报中披露持有 MAZE(MAZE THERAPEUTICS INC)1,035,910 股,市值约 US$30.9M,约占其申报组合的 16.40%,在其申报持仓中市值排名第 4 位。 General Catalyst Group Management, LLC 最近 6 个申报季度中有 6 个季度披露了 MAZE 持仓,最早可追溯至 Q1 2025。

最新持仓 (Q2 2026)1.04M 股
申报持仓市值$30.91M
组合权重16.40%
首次申报Q1 2025
最近变动持有
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

General Catalyst Group Management, LLC 对 MAZE 的持仓演变

General Catalyst Group Management, LLC 于 Q1 2025 首次披露 MAZE 持仓:1,035,910 股(约 US$11.4M)。 该持仓在 Q4 2025 达到峰值 1,035,910 股,市值约 US$42.9M。 在 6 次申报中,General Catalyst Group Management, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 1,035,910 股、市值约 US$30.9M。

逐季持仓明细

季度股数金额变化
Q1 2025 1.04M $11.41M 新进
Q2 2025 1.04M $12.71M 持有
Q3 2025 1.04M $26.86M 持有
Q4 2025 1.04M $42.92M 持有
Q1 2026 1.04M $30.92M 持有
Q2 2026 1.04M $30.91M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 MAZE 与 13F 数据

MAZE(MAZE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 74 只申报持有 MAZE,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$150.2M), TRV GP IV, LLC (US$133.5M), ARCH Venture Management, LLC (US$123.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MAZE 的基金

查看 MAZE 的全部基金持有人 →

常见问题

How long has General Catalyst Group Management, LLC held MAZE?

General Catalyst Group Management, LLC has disclosed MAZE holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is General Catalyst Group Management, LLC's current position in MAZE?

As of Q2 2026, General Catalyst Group Management, LLC holds 1.04M shares of MAZE (MAZE THERAPEUTICS INC), valued at $30.91M, representing 16.40% of its reported portfolio and ranking #4.

Has General Catalyst Group Management, LLC been buying or selling MAZE?

In the latest 13F filing (Q2 2026), General Catalyst Group Management, LLC held unchanged its position in MAZE. The position peaked in Q4 2025 at 1.04M shares.

Which other funds hold MAZE?

Other major institutional holders of MAZE include Frazier Life Sciences Management, L.P., TRV GP IV, LLC, ARCH Venture Management, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.